Literature DB >> 10691802

Renal sodium/calcium exchange; a vasodilator that is defective in salt-sensitive hypertension.

P D Bell1, N Mashburn, M T Unlap.   

Abstract

The Na+ : Ca2+ exchanger is an important plasma membrane ion transport pathway that plays a major role in controlling [Ca2+]i. In smooth muscle cells, it may function as a Ca2+ extrusion pathway and may help lower [Ca2+]i in response to vasoconstrictor-induced increases in [Ca2+]i. It may also extrude [Ca2+]i and lead to vasodilation in response to vasodilators. Our recent studies have been performed to determine the existence and regulation of the Na+ : Ca2+ exchanger in renal contractile cells which include afferent and efferent arterioles and mesangial cells. Exchanger activity is present in all three of these contractile elements but is higher in afferent arterioles vs. efferent arterioles. We have also examined the role of altered regulation of the exchanger in the SHR and in salt-sensitive hypertension. With the establishment of high blood pressure, Na+ : Ca2+ exchanger activity is reduced in afferent but not in efferent arterioles in both models of hypertension. Other works in cultured mesangial cells and freshly dissected afferent arterioles, have shown that protein kinase C (PKC) up-regulates the Na+ : Ca2+ exchanger from Dahl/Rapp salt-resistant rats while it fails to do so in arterioles and mesangial cells from salt-sensitive rats. This defect in PKC regulation of Na+ : Ca2+ exchange is the result of a loss of PKC-mediated translocation of the exchanger to the plasma membrane in S mesangial cells. Thus, a defect in the PKC-Na+ : Ca2+ exchanger-translocation pathway may cause dysregulation of [Ca2+]i and help explain the dramatic decrease in GFR that occurs in this model of hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691802     DOI: 10.1046/j.1365-201x.2000.00671.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  10 in total

Review 1.  Role of central mineralocorticoid receptors in cardiovascular disease.

Authors:  C E Gomez-Sanchez; E P Gomez-Sanchez
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Attenuated renal vascular responses to acute angiotensin II infusion in smooth muscle-specific Na+/Ca2+ exchanger knockout mice.

Authors:  Di Zhao; Jin Zhang; Mordecai P Blaustein; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-22

Review 3.  Protein kinase C isoforms as specific targets for modulation of vascular smooth muscle function in hypertension.

Authors:  Daisy A Salamanca; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2005-09-01       Impact factor: 5.858

4.  Effects of renal Na+/Ca2+ exchanger 1 inhibitor (SEA0400) treatment on electrolytes, renal function and hemodynamics in rats.

Authors:  Midori Sasaki Yatabe; Junichi Yatabe; Kozue Takano; Hironobu Sanada; Junko Kimura; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-11-20       Impact factor: 2.801

5.  Action of thiazide on renal interstitial calcium.

Authors:  Shaleka L Eley; Crystal M Allen; Cicely L Williams; Richard D Bukoski; Mildred A Pointer
Journal:  Am J Hypertens       Date:  2008-05-01       Impact factor: 2.689

Review 6.  Cellular mediators of renal vascular dysfunction in hypertension.

Authors:  Bharathy Ponnuchamy; Raouf A Khalil
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

7.  Effects of amiloride, benzamil, and alterations in extracellular Na+ on the rat afferent arteriole and its myogenic response.

Authors:  Xuemei Wang; Kosuke Takeya; Philip I Aaronson; Kathy Loutzenhiser; Rodger Loutzenhiser
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-21

8.  Contribution of Na+ -Ca2+ exchanger to pinacidil-induced relaxation in the rat mesenteric artery.

Authors:  Suk Ying Tsang; Xiaoqiang Yao; Chi Ming Wong; Chak Leung Au; Zhen Yu Chen; Yu Huang
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

9.  Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes.

Authors:  B K Lee; G S Lee; W F Stewart; K D Ahn; D Simon; K T Kelsey; A C Todd; B S Schwartz
Journal:  Environ Health Perspect       Date:  2001-04       Impact factor: 9.031

10.  Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease.

Authors:  Raouf A Khalil
Journal:  Pharmaceuticals (Basel)       Date:  2013
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.